Boston Scientific's Q1 2025 Endoscopy sales jump 6%, powered by innovation in stents, clips and surgical tools for GI care.

Boston Scientific’s BSX Endoscopy business develops and ... A key highlight was the continued double-digit growth of the AXIOS Stent and Electrocautery Enhanced Delivery System. AXIOS is the first and ...

Outlook: Boston Scientific forecasts net sales growth of approximately 15%-17% in 2025 on a reported basis and around 12%-14% on an organic basis, compared to prior guidance of 12.5%-14.5% and 10% ...

Shares of Boston Scientific slipped 0.7% to $105.46 in early trading Wednesday, while shares of Edwards rose 1.8% to $77.60 and shares of Medtronic gained 1.1% to $82.06.

Police in Boston, Massachusetts, identified a man allegedly caught on camera hitting someone's car with a hatchet in an apparent road rage incident. The Boston Police Department announced that 27 ...

Boston Scientific Chairman and CEO Michael Mahoney purchased a waterfront house in Lost Tree Village, North Palm Beach for $17.3 million through his Blue Sky Trust. The 6,400-square-foot house, at ...

Five things you need to know today, including Boston Scientific, dorm construction, Primark and a new face in the BBJ newsroom 2025 Inno Under 25 Inno Under 25 is our annual list of rising ...

Ines Boehnert, Thermo Fisher Scientific By Don Seiffert – Managing Editor, Boston Business Journal May 18, 2025 Preview this article 1 min ...

Though Boston Scientific brought in $4.66 billion in revenue for the first quarter of 2025, up 20.9% year over year, the medical devicemaker is bracing for a potential $200 million hit in the ...

Boston Scientific Corporation (NYSE:BSX) Q1 2025 Earnings Call Transcript April 23, 2025 Boston Scientific Corporation beats earnings expectations. Reported EPS is $0.75, expectations were $0.673 ...

For the full year, Boston Scientific sees adjusted EPS of $2.87 to $2.94 and sales up 15% to 17%, above Visible Alpha projections.